Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 40 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.
¿Cuáles son los estados financieros clave de Park Ha Biological Technology Co Ltd?
Según el último estado financiero (Form-10K), Park Ha Biological Technology Co Ltd tiene un total de activos de $0, una ganancia neta 損失 de $0
¿Cuáles son los ratios financieros clave para BYAH?
El ratio corriente de Park Ha Biological Technology Co Ltd es 0, el margen neto es 0, las ventas por acción son $0.
¿Cómo se desglosan los ingresos de Park Ha Biological Technology Co Ltd por segmento o geografía?
Park Ha Biological Technology Co Ltd の最大収益セグメントは Franchise Fees で、最新の利益発表における収益は 1,510,809 です。地域別に見ると、China が Park Ha Biological Technology Co Ltd の主要市場であり、収益は 2,524,843 です。
¿Es rentable Park Ha Biological Technology Co Ltd?
いいえ, según los últimos estados financieros, Park Ha Biological Technology Co Ltd tiene una ganancia neta 損失 de $0
¿Tiene Park Ha Biological Technology Co Ltd alguna deuda?
いいえ, Park Ha Biological Technology Co Ltd tiene una deuda de 0
¿Cuántas acciones en circulación tiene Park Ha Biological Technology Co Ltd?
Park Ha Biological Technology Co Ltd tiene un total de acciones en circulación de 0